 | • レポートコード：MRC2312MG08595 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の低分子原薬＆中間体市場規模と予測を収録しています。・世界の低分子原薬＆中間体市場：売上、2018年-2023年、2024年-2029年 ・世界の低分子原薬＆中間体市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の低分子原薬＆中間体市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「原薬」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 低分子原薬＆中間体のグローバル主要企業は、Asymchem、 Cipla、 Merck、 Aurobindo Pharma、 Teva Pharmaceutical Industries、 Viatris、 Bristol-Myers Squibb、 Boehringer Ingelheim International、 AbbVie、 Sun Pharmaceutical Industries、 Dr. Reddy's Laboratories、 Albermarle Corporation、 Cytovance Biologics、 Zhejiang Ausun Pharmaceutical、 Zhejiang Jiuzhou Pharmaceutical、 Shenzhen BORUI Pharmaceutical Technology、 Shanghai Haoyuan Chemexpress、 Hangzhou Xinqiao Biotechnologyなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、低分子原薬＆中間体のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の低分子原薬＆中間体市場：タイプ別、2018年-2023年、2024年-2029年 世界の低分子原薬＆中間体市場：タイプ別市場シェア、2022年 ・原薬、中間体 世界の低分子原薬＆中間体市場：用途別、2018年-2023年、2024年-2029年 世界の低分子原薬＆中間体市場：用途別市場シェア、2022年 ・臨床治療、医学研究 世界の低分子原薬＆中間体市場：地域・国別、2018年-2023年、2024年-2029年 世界の低分子原薬＆中間体市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における低分子原薬＆中間体のグローバル売上、2018年-2023年 ・主要企業における低分子原薬＆中間体のグローバル売上シェア、2022年 ・主要企業における低分子原薬＆中間体のグローバル販売量、2018年-2023年 ・主要企業における低分子原薬＆中間体のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Asymchem、 Cipla、 Merck、 Aurobindo Pharma、 Teva Pharmaceutical Industries、 Viatris、 Bristol-Myers Squibb、 Boehringer Ingelheim International、 AbbVie、 Sun Pharmaceutical Industries、 Dr. Reddy's Laboratories、 Albermarle Corporation、 Cytovance Biologics、 Zhejiang Ausun Pharmaceutical、 Zhejiang Jiuzhou Pharmaceutical、 Shenzhen BORUI Pharmaceutical Technology、 Shanghai Haoyuan Chemexpress、 Hangzhou Xinqiao Biotechnology ************************************************************* ・調査・分析レポートの概要 低分子原薬＆中間体市場の定義 市場セグメント 世界の低分子原薬＆中間体市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の低分子原薬＆中間体市場規模 世界の低分子原薬＆中間体市場規模：2022年 VS 2029年 世界の低分子原薬＆中間体市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの低分子原薬＆中間体の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の低分子原薬＆中間体製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：原薬、中間体 低分子原薬＆中間体のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：臨床治療、医学研究 低分子原薬＆中間体の用途別グローバル売上・予測 ・地域別市場分析 地域別低分子原薬＆中間体市場規模 2022年と2029年 地域別低分子原薬＆中間体売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Asymchem、 Cipla、 Merck、 Aurobindo Pharma、 Teva Pharmaceutical Industries、 Viatris、 Bristol-Myers Squibb、 Boehringer Ingelheim International、 AbbVie、 Sun Pharmaceutical Industries、 Dr. Reddy's Laboratories、 Albermarle Corporation、 Cytovance Biologics、 Zhejiang Ausun Pharmaceutical、 Zhejiang Jiuzhou Pharmaceutical、 Shenzhen BORUI Pharmaceutical Technology、 Shanghai Haoyuan Chemexpress、 Hangzhou Xinqiao Biotechnology ... |
This research report provides a comprehensive analysis of the Small Molecule API and Intermediates market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Small Molecule API and Intermediates market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Small Molecule API and Intermediates, challenges faced by the industry, and potential opportunities for market players.
The global Small Molecule API and Intermediates market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Small Molecule API and Intermediates market presents opportunities for various stakeholders, including Clinical Treatment, Medical Research. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Small Molecule API and Intermediates market. Additionally, the growing consumer demand present avenues for market expansion.
The global Small Molecule API and Intermediates market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Small molecule APIs and intermediates play an important role in drug development and manufacturing. Small-molecule APIs are the active ingredients of drugs and have biological activity to treat target diseases. After they are synthesized, purified and formed into pharmaceutical preparations, they can be absorbed and utilized by the human body through oral administration, injection and other routes. Intermediates are precursors of small-molecule APIs that are transformed into final drugs through successive synthetic steps. The selection and optimization of intermediates is crucial to the efficiency and economy of the entire synthetic route. Small molecule APIs and intermediates are an integral part of drug development and manufacturing. By optimizing and controlling its synthesis and purification process, high-quality, high-efficiency, and safe drug products can be obtained, providing effective treatments for human health.
Key Features:
The research report on the Small Molecule API and Intermediates market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Small Molecule API and Intermediates market.
Market Overview: The report provides a comprehensive overview of the Small Molecule API and Intermediates market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., API, Intermediate), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Small Molecule API and Intermediates market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Small Molecule API and Intermediates market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Small Molecule API and Intermediates market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Small Molecule API and Intermediates market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Small Molecule API and Intermediates market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Small Molecule API and Intermediates market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Small Molecule API and Intermediates, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Small Molecule API and Intermediates market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Small Molecule API and Intermediates market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
API
Intermediate
Market segment by Application
Clinical Treatment
Medical Research
Global Small Molecule API and Intermediates Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Asymchem
Cipla
Merck
Aurobindo Pharma
Teva Pharmaceutical Industries
Viatris
Bristol-Myers Squibb
Boehringer Ingelheim International
AbbVie
Sun Pharmaceutical Industries
Dr. Reddy’s Laboratories
Albermarle Corporation
Cytovance Biologics
Zhejiang Ausun Pharmaceutical
Zhejiang Jiuzhou Pharmaceutical
Shenzhen BORUI Pharmaceutical Technology
Shanghai Haoyuan Chemexpress
Hangzhou Xinqiao Biotechnology
Outline of Major Chapters:
Chapter 1: Introduces the definition of Small Molecule API and Intermediates, market overview.
Chapter 2: Global Small Molecule API and Intermediates market size in revenue and volume.
Chapter 3: Detailed analysis of Small Molecule API and Intermediates manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Small Molecule API and Intermediates in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Small Molecule API and Intermediates capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Small Molecule API and Intermediates Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Small Molecule API and Intermediates Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Small Molecule API and Intermediates Overall Market Size
2.1 Global Small Molecule API and Intermediates Market Size: 2022 VS 2029
2.2 Global Small Molecule API and Intermediates Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Small Molecule API and Intermediates Sales: 2018-2029
3 Company Landscape
3.1 Top Small Molecule API and Intermediates Players in Global Market
3.2 Top Global Small Molecule API and Intermediates Companies Ranked by Revenue
3.3 Global Small Molecule API and Intermediates Revenue by Companies
3.4 Global Small Molecule API and Intermediates Sales by Companies
3.5 Global Small Molecule API and Intermediates Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Small Molecule API and Intermediates Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Small Molecule API and Intermediates Product Type
3.8 Tier 1, Tier 2 and Tier 3 Small Molecule API and Intermediates Players in Global Market
3.8.1 List of Global Tier 1 Small Molecule API and Intermediates Companies
3.8.2 List of Global Tier 2 and Tier 3 Small Molecule API and Intermediates Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Small Molecule API and Intermediates Market Size Markets, 2022 & 2029
4.1.2 API
4.1.3 Intermediate
4.2 By Type – Global Small Molecule API and Intermediates Revenue & Forecasts
4.2.1 By Type – Global Small Molecule API and Intermediates Revenue, 2018-2023
4.2.2 By Type – Global Small Molecule API and Intermediates Revenue, 2024-2029
4.2.3 By Type – Global Small Molecule API and Intermediates Revenue Market Share, 2018-2029
4.3 By Type – Global Small Molecule API and Intermediates Sales & Forecasts
4.3.1 By Type – Global Small Molecule API and Intermediates Sales, 2018-2023
4.3.2 By Type – Global Small Molecule API and Intermediates Sales, 2024-2029
4.3.3 By Type – Global Small Molecule API and Intermediates Sales Market Share, 2018-2029
4.4 By Type – Global Small Molecule API and Intermediates Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Small Molecule API and Intermediates Market Size, 2022 & 2029
5.1.2 Clinical Treatment
5.1.3 Medical Research
5.2 By Application – Global Small Molecule API and Intermediates Revenue & Forecasts
5.2.1 By Application – Global Small Molecule API and Intermediates Revenue, 2018-2023
5.2.2 By Application – Global Small Molecule API and Intermediates Revenue, 2024-2029
5.2.3 By Application – Global Small Molecule API and Intermediates Revenue Market Share, 2018-2029
5.3 By Application – Global Small Molecule API and Intermediates Sales & Forecasts
5.3.1 By Application – Global Small Molecule API and Intermediates Sales, 2018-2023
5.3.2 By Application – Global Small Molecule API and Intermediates Sales, 2024-2029
5.3.3 By Application – Global Small Molecule API and Intermediates Sales Market Share, 2018-2029
5.4 By Application – Global Small Molecule API and Intermediates Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Small Molecule API and Intermediates Market Size, 2022 & 2029
6.2 By Region – Global Small Molecule API and Intermediates Revenue & Forecasts
6.2.1 By Region – Global Small Molecule API and Intermediates Revenue, 2018-2023
6.2.2 By Region – Global Small Molecule API and Intermediates Revenue, 2024-2029
6.2.3 By Region – Global Small Molecule API and Intermediates Revenue Market Share, 2018-2029
6.3 By Region – Global Small Molecule API and Intermediates Sales & Forecasts
6.3.1 By Region – Global Small Molecule API and Intermediates Sales, 2018-2023
6.3.2 By Region – Global Small Molecule API and Intermediates Sales, 2024-2029
6.3.3 By Region – Global Small Molecule API and Intermediates Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Small Molecule API and Intermediates Revenue, 2018-2029
6.4.2 By Country – North America Small Molecule API and Intermediates Sales, 2018-2029
6.4.3 US Small Molecule API and Intermediates Market Size, 2018-2029
6.4.4 Canada Small Molecule API and Intermediates Market Size, 2018-2029
6.4.5 Mexico Small Molecule API and Intermediates Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Small Molecule API and Intermediates Revenue, 2018-2029
6.5.2 By Country – Europe Small Molecule API and Intermediates Sales, 2018-2029
6.5.3 Germany Small Molecule API and Intermediates Market Size, 2018-2029
6.5.4 France Small Molecule API and Intermediates Market Size, 2018-2029
6.5.5 U.K. Small Molecule API and Intermediates Market Size, 2018-2029
6.5.6 Italy Small Molecule API and Intermediates Market Size, 2018-2029
6.5.7 Russia Small Molecule API and Intermediates Market Size, 2018-2029
6.5.8 Nordic Countries Small Molecule API and Intermediates Market Size, 2018-2029
6.5.9 Benelux Small Molecule API and Intermediates Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Small Molecule API and Intermediates Revenue, 2018-2029
6.6.2 By Region – Asia Small Molecule API and Intermediates Sales, 2018-2029
6.6.3 China Small Molecule API and Intermediates Market Size, 2018-2029
6.6.4 Japan Small Molecule API and Intermediates Market Size, 2018-2029
6.6.5 South Korea Small Molecule API and Intermediates Market Size, 2018-2029
6.6.6 Southeast Asia Small Molecule API and Intermediates Market Size, 2018-2029
6.6.7 India Small Molecule API and Intermediates Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Small Molecule API and Intermediates Revenue, 2018-2029
6.7.2 By Country – South America Small Molecule API and Intermediates Sales, 2018-2029
6.7.3 Brazil Small Molecule API and Intermediates Market Size, 2018-2029
6.7.4 Argentina Small Molecule API and Intermediates Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Small Molecule API and Intermediates Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Small Molecule API and Intermediates Sales, 2018-2029
6.8.3 Turkey Small Molecule API and Intermediates Market Size, 2018-2029
6.8.4 Israel Small Molecule API and Intermediates Market Size, 2018-2029
6.8.5 Saudi Arabia Small Molecule API and Intermediates Market Size, 2018-2029
6.8.6 UAE Small Molecule API and Intermediates Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Asymchem
7.1.1 Asymchem Company Summary
7.1.2 Asymchem Business Overview
7.1.3 Asymchem Small Molecule API and Intermediates Major Product Offerings
7.1.4 Asymchem Small Molecule API and Intermediates Sales and Revenue in Global (2018-2023)
7.1.5 Asymchem Key News & Latest Developments
7.2 Cipla
7.2.1 Cipla Company Summary
7.2.2 Cipla Business Overview
7.2.3 Cipla Small Molecule API and Intermediates Major Product Offerings
7.2.4 Cipla Small Molecule API and Intermediates Sales and Revenue in Global (2018-2023)
7.2.5 Cipla Key News & Latest Developments
7.3 Merck
7.3.1 Merck Company Summary
7.3.2 Merck Business Overview
7.3.3 Merck Small Molecule API and Intermediates Major Product Offerings
7.3.4 Merck Small Molecule API and Intermediates Sales and Revenue in Global (2018-2023)
7.3.5 Merck Key News & Latest Developments
7.4 Aurobindo Pharma
7.4.1 Aurobindo Pharma Company Summary
7.4.2 Aurobindo Pharma Business Overview
7.4.3 Aurobindo Pharma Small Molecule API and Intermediates Major Product Offerings
7.4.4 Aurobindo Pharma Small Molecule API and Intermediates Sales and Revenue in Global (2018-2023)
7.4.5 Aurobindo Pharma Key News & Latest Developments
7.5 Teva Pharmaceutical Industries
7.5.1 Teva Pharmaceutical Industries Company Summary
7.5.2 Teva Pharmaceutical Industries Business Overview
7.5.3 Teva Pharmaceutical Industries Small Molecule API and Intermediates Major Product Offerings
7.5.4 Teva Pharmaceutical Industries Small Molecule API and Intermediates Sales and Revenue in Global (2018-2023)
7.5.5 Teva Pharmaceutical Industries Key News & Latest Developments
7.6 Viatris
7.6.1 Viatris Company Summary
7.6.2 Viatris Business Overview
7.6.3 Viatris Small Molecule API and Intermediates Major Product Offerings
7.6.4 Viatris Small Molecule API and Intermediates Sales and Revenue in Global (2018-2023)
7.6.5 Viatris Key News & Latest Developments
7.7 Bristol-Myers Squibb
7.7.1 Bristol-Myers Squibb Company Summary
7.7.2 Bristol-Myers Squibb Business Overview
7.7.3 Bristol-Myers Squibb Small Molecule API and Intermediates Major Product Offerings
7.7.4 Bristol-Myers Squibb Small Molecule API and Intermediates Sales and Revenue in Global (2018-2023)
7.7.5 Bristol-Myers Squibb Key News & Latest Developments
7.8 Boehringer Ingelheim International
7.8.1 Boehringer Ingelheim International Company Summary
7.8.2 Boehringer Ingelheim International Business Overview
7.8.3 Boehringer Ingelheim International Small Molecule API and Intermediates Major Product Offerings
7.8.4 Boehringer Ingelheim International Small Molecule API and Intermediates Sales and Revenue in Global (2018-2023)
7.8.5 Boehringer Ingelheim International Key News & Latest Developments
7.9 AbbVie
7.9.1 AbbVie Company Summary
7.9.2 AbbVie Business Overview
7.9.3 AbbVie Small Molecule API and Intermediates Major Product Offerings
7.9.4 AbbVie Small Molecule API and Intermediates Sales and Revenue in Global (2018-2023)
7.9.5 AbbVie Key News & Latest Developments
7.10 Sun Pharmaceutical Industries
7.10.1 Sun Pharmaceutical Industries Company Summary
7.10.2 Sun Pharmaceutical Industries Business Overview
7.10.3 Sun Pharmaceutical Industries Small Molecule API and Intermediates Major Product Offerings
7.10.4 Sun Pharmaceutical Industries Small Molecule API and Intermediates Sales and Revenue in Global (2018-2023)
7.10.5 Sun Pharmaceutical Industries Key News & Latest Developments
7.11 Dr. Reddy’s Laboratories
7.11.1 Dr. Reddy’s Laboratories Company Summary
7.11.2 Dr. Reddy’s Laboratories Business Overview
7.11.3 Dr. Reddy’s Laboratories Small Molecule API and Intermediates Major Product Offerings
7.11.4 Dr. Reddy’s Laboratories Small Molecule API and Intermediates Sales and Revenue in Global (2018-2023)
7.11.5 Dr. Reddy’s Laboratories Key News & Latest Developments
7.12 Albermarle Corporation
7.12.1 Albermarle Corporation Company Summary
7.12.2 Albermarle Corporation Business Overview
7.12.3 Albermarle Corporation Small Molecule API and Intermediates Major Product Offerings
7.12.4 Albermarle Corporation Small Molecule API and Intermediates Sales and Revenue in Global (2018-2023)
7.12.5 Albermarle Corporation Key News & Latest Developments
7.13 Cytovance Biologics
7.13.1 Cytovance Biologics Company Summary
7.13.2 Cytovance Biologics Business Overview
7.13.3 Cytovance Biologics Small Molecule API and Intermediates Major Product Offerings
7.13.4 Cytovance Biologics Small Molecule API and Intermediates Sales and Revenue in Global (2018-2023)
7.13.5 Cytovance Biologics Key News & Latest Developments
7.14 Zhejiang Ausun Pharmaceutical
7.14.1 Zhejiang Ausun Pharmaceutical Company Summary
7.14.2 Zhejiang Ausun Pharmaceutical Business Overview
7.14.3 Zhejiang Ausun Pharmaceutical Small Molecule API and Intermediates Major Product Offerings
7.14.4 Zhejiang Ausun Pharmaceutical Small Molecule API and Intermediates Sales and Revenue in Global (2018-2023)
7.14.5 Zhejiang Ausun Pharmaceutical Key News & Latest Developments
7.15 Zhejiang Jiuzhou Pharmaceutical
7.15.1 Zhejiang Jiuzhou Pharmaceutical Company Summary
7.15.2 Zhejiang Jiuzhou Pharmaceutical Business Overview
7.15.3 Zhejiang Jiuzhou Pharmaceutical Small Molecule API and Intermediates Major Product Offerings
7.15.4 Zhejiang Jiuzhou Pharmaceutical Small Molecule API and Intermediates Sales and Revenue in Global (2018-2023)
7.15.5 Zhejiang Jiuzhou Pharmaceutical Key News & Latest Developments
7.16 Shenzhen BORUI Pharmaceutical Technology
7.16.1 Shenzhen BORUI Pharmaceutical Technology Company Summary
7.16.2 Shenzhen BORUI Pharmaceutical Technology Business Overview
7.16.3 Shenzhen BORUI Pharmaceutical Technology Small Molecule API and Intermediates Major Product Offerings
7.16.4 Shenzhen BORUI Pharmaceutical Technology Small Molecule API and Intermediates Sales and Revenue in Global (2018-2023)
7.16.5 Shenzhen BORUI Pharmaceutical Technology Key News & Latest Developments
7.17 Shanghai Haoyuan Chemexpress
7.17.1 Shanghai Haoyuan Chemexpress Company Summary
7.17.2 Shanghai Haoyuan Chemexpress Business Overview
7.17.3 Shanghai Haoyuan Chemexpress Small Molecule API and Intermediates Major Product Offerings
7.17.4 Shanghai Haoyuan Chemexpress Small Molecule API and Intermediates Sales and Revenue in Global (2018-2023)
7.17.5 Shanghai Haoyuan Chemexpress Key News & Latest Developments
7.18 Hangzhou Xinqiao Biotechnology
7.18.1 Hangzhou Xinqiao Biotechnology Company Summary
7.18.2 Hangzhou Xinqiao Biotechnology Business Overview
7.18.3 Hangzhou Xinqiao Biotechnology Small Molecule API and Intermediates Major Product Offerings
7.18.4 Hangzhou Xinqiao Biotechnology Small Molecule API and Intermediates Sales and Revenue in Global (2018-2023)
7.18.5 Hangzhou Xinqiao Biotechnology Key News & Latest Developments
8 Global Small Molecule API and Intermediates Production Capacity, Analysis
8.1 Global Small Molecule API and Intermediates Production Capacity, 2018-2029
8.2 Small Molecule API and Intermediates Production Capacity of Key Manufacturers in Global Market
8.3 Global Small Molecule API and Intermediates Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Small Molecule API and Intermediates Supply Chain Analysis
10.1 Small Molecule API and Intermediates Industry Value Chain
10.2 Small Molecule API and Intermediates Upstream Market
10.3 Small Molecule API and Intermediates Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Small Molecule API and Intermediates Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer